New Ways to Manage Celiac Disease
Official title: Evaluation of Novel Technologies to Improve Clinical Management of Celiac Disease: The GLUTECH Trial
Funded at Columbia University Health Sciences · NIH-11117054 · Data updated 2026-11-12
This project helps adults with celiac disease manage their gluten-free diet better using new technologies and telemedicine.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | September 15, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2025 |
| Award (this year) | $1,400,000 |
| NIH project number | 5U01DK136523-03 |
| Project ID | NIH-11117054 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are adults aged 21 and older who have celiac disease and are looking for new ways to manage their gluten-free diet.
✕Less likely to help
Patients who do not have celiac disease or are not interested in using new technologies for diet management may not receive direct benefit from this particular approach.
What this research studies
Celiac disease can be challenging to manage, and sticking to a strict gluten-free diet is the only proven treatment. Many people don't get regular support from dietitians, and the disease can lead to serious health issues like anemia, infertility, and osteoporosis. This project explores how new tools, such as portable gluten sensors for food and urine tests, combined with virtual dietitian visits, can help you better understand and avoid gluten exposures. The goal is to make managing your diet easier and improve your overall health and quality of life.
Why it matters
Potential benefit: If successful, this approach could make it easier for people with celiac disease to follow their gluten-free diet, potentially reducing complications and improving their well-being.
How similar studies have gone: While the individual technologies have shown validity, this specific combination of novel gluten detection technologies with telemedicine for celiac disease management is being rigorously tested in this project.
Where this research is happening
-
Columbia University Health Sciences
New York, United States Active
Researchers
- Principal investigator: Lebwohl, Benjamin — Columbia University Health Sciences
- Study coordinator: Lebwohl, Benjamin
Related research
Other NIH-funded projects on the same topics.
-
Understanding how immune cells interact in celiac disease to guide healing
A study from the University of Chicago will follow people with celiac disease to understand how immune cells in the gut contribute to damage or healing when gluten is present or restricted.
-
NanoDiscs: a new way to calm the immune system in celiac disease
A new, protein-like particle called NanoDiscs is being developed to deliver safe targets to the immune system in people with celiac disease, with the goal of reducing reactions to gluten.
-
Tissue damage and healing in Celiac Disease
A broad study at the University of Chicago is exploring why some people with celiac disease keep having symptoms and tissue damage even when they try to follow a gluten-free diet.
-
Gluten-detection devices and telemedicine to help adults with celiac disease
This project looks at whether using portable gluten sensors and urine gluten tests together with telemedicine can help adults with celiac disease stick to a gluten-free diet and feel better.
-
Gluten-sensing tech to help manage celiac disease with telemedicine
A study tests new gluten-detection tools used with online care to help adults with celiac disease manage their condition.
-
Role of Transglutaminase 2 in Celiac Disease
A study from Stanford aims to understand how a specific enzyme, TG2, contributes to celiac disease and to test a potential gut-focused treatment that could one day help people avoid dietary controls.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.